Results 141 to 150 of about 174,156 (175)

Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase

Human Molecular Genetics, 1995
Lennart Hammarström, C. I. Edvard Smith, A. David B. Webster, Geneviève de Saint Basile, Liping Luo, Igor Vořechovský, Igor Vořechovský   +6 more
semanticscholar   +5 more sources

Pillars Article: The Gene Involved in X-linked Agammaglobulinaemia Is a Member of the Src Family of Protein-Tyrosine Kinases. Nature. 1993. 361: 226–233

The Journal of Immunology, 2012
David Vetrie, Igor Vořechovský, Paschalis Sideras, Jill Holland, Angela Davies, Frances Flinter, Lennart Hammarström, Christine Kinnon, Roland Levinsky, Martin Bobrow, C I Edvard Smith, David R Bentley   +11 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Lenalidomide/rituximab

Reactions weekly, 2022

semanticscholar   +1 more source

The SH3 Domain of Bruton's Tyrosine Kinase Interacts with Vav, Sam68 and EWS

Scandinavian Journal of Immunology, 1997
R. Guinamard, M. Fougereau, P. Seckinger
semanticscholar   +1 more source

Signalling of Bruton's Tyrosine Kinase, Btk

Scandinavian Journal of Immunology, 1999
A. J. Mohamed, B. Nore, Birger Christensson, C. I. E. Smith   +3 more
semanticscholar   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).

Human Molecular Genetics, 1995
H. Jin, A. Webster, M. Vihinen, P. Sideras, I. Vořechovský, Lennart Hammarstrom, E. Bernatowska-Matuszkiewicz, C. I. Smith, M. Bobrow, D. Vetrie   +9 more
semanticscholar   +1 more source

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

Nature Reviews Clinical Oncology, 2016
Fausto Castagnetti, Michele Baccarani
exaly